GlassScriptPhysician profile
Seth D Zitwer
NPI 1326008749
$727.86
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $136 · 2021: $247 · 2022: $62.22.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $173.31 | 2019-2022 | |
| Abbott Laboratories | $92.88 | 2020-2022 | |
| Novo Nordisk INC | $66.00 | 2019-2020 | |
| Lilly USA, LLC | $59.77 | 2019-2021 | |
| Glaxosmithkline, LLC. | $55.30 | 2019-2021 | |
| Amarin Pharma, INC. | $47.20 | 2019-2021 | |
| Pfizer INC. | $40.45 | 2021 | |
| Janssen Pharmaceuticals, INC | $35.03 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $32.72 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.80 | 2019 | |
| Sanofi-Aventis U.S. LLC | $22.42 | 2020 | |
| Esperion Therapeutics, INC. | $21.79 | 2020 | |
| Allergan, INC. | $19.72 | 2019 | |
| Amgen INC. | $18.06 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $11.41 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Zitwer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.